Top Markets
Coin of the day
Excelsior Biopharma Inc. Excelsior Biopharma Inc.

Excelsior Biopharma Inc.

6496
Pozycja w akcjach #26872
Excelsior Biopharma Inc., established in 1988 and headquartered in Taipei,... Excelsior Biopharma Inc., established in 1988 and headquartered in Taipei, Taiwan, functions as a pharmaceutical enterprise with a global market presence, encompassing Taiwan, China, and other international regions. The company offers a comprehensive range of healthcare solutions, including prescription and over-the-counter medications, medical devices, nutritional supplements, and various medical supplies. Excelsior addresses numerous therapeutic areas such as pediatrics, gastroenterology, neurology, cardiology, dermatology, medical toxicology, dentistry, obstetrics, oncology, hematology, otorhinolaryngology, and infectious disease management. Its product line also features specialized diagnostic kits under the Actim brand for identifying conditions like influenza virus, fecal occult blood, acute pancreatitis, and for assessing preterm or full-week delivery and early membrane rupture. Moreover, the company provides oral hygiene products, including toothpaste, mouthwash, and gels, under the Oral7 name. Beyond product sales, Excelsior is involved in the import and export of active pharmaceutical ingredients, as well as engaging in technological research, facilitating pharmaceutical technology transfer, and participating in collaborative development and improvement initiatives. The company adopted its current name, Excelsior Biopharma Inc., in June 2003, having previously been known as Excelsior Enterprise Co., Ltd.
Cena akcji
$0.7949757
Ostatnia synchronizacja: 2026-08-19
Kapitalizacja rynkowa
$36.94M
Zmiana (1 dzień)
0.40%
Zmiana (1 rok)
-15.50%
Kraj
TW
Handel Excelsior Biopharma Inc. (6496)

Kategoria

Cena 6496 z kapitalizacją rynkową B
Excelsior Biopharma Inc. Excelsior Biopharma Inc.
6496
$0.7949757
Kapitalizacja rynkowa Excelsior Biopharma Inc.(6496)
Kapitalizacja rynkowa: $36.94M
Na dzień August 2026 spółka Excelsior Biopharma Inc. ma kapitalizację rynkową wynoszącą $36.94M. Według naszych danych, czyni to Excelsior Biopharma Inc. 26872nd najcenniejszą firmą na świecie pod względem kapitalizacji rynkowej. Kapitalizacja rynkowa to całkowita wartość rynkowa wszystkich wyemitowanych akcji spółki giełdowej i jest powszechnie stosowana do oceny jej wartości.
Historia kapitalizacji rynkowej Excelsior Biopharma Inc. od 2014 do 2026
6496 w porównaniu do 5 najpopularniejszych stocks
Cena za 6496 Aktywa B Kapitalizacja rynkowa B Wyniki
Excelsior Biopharma Inc. Excelsior Biopharma Inc.
$114,058 $36.94M
$5.301T +14,347,243.72%
Excelsior Biopharma Inc. Excelsior Biopharma Inc.
$99,706.17 $36.94M
$4.634T +12,541,939.99%
Excelsior Biopharma Inc. Excelsior Biopharma Inc.
$89,143.83 $36.94M
$4.143T +11,213,303.09%
Excelsior Biopharma Inc. Excelsior Biopharma Inc.
$77,231.94 $36.94M
$3.589T +9,714,906.08%
Excelsior Biopharma Inc. Excelsior Biopharma Inc.
$61,472.49 $36.94M
$2.857T +7,732,524.96%